CDH2 and cancer: Through suppressing the key of enzymes of glycolysis LDHA and mitochondrial metabolism PDK1, induced by TGF-β1, the mesenchymal subtype markers N-cadherin and Vimentin are negated, suggesting that the metabolic reprogramming is directly related to cancer metastasis.